Impaired release of tissue plasminogen activator from the endothelium in Graves' disease - indicator of endothelial dysfunction and reduced fibrinolytic capacity
- 25 December 1998
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 28 (12) , 1050-1054
- https://doi.org/10.1046/j.1365-2362.1998.00381.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Activation of Tissue Factor–Induced Coagulation and Endothelial Cell Dysfunction in Non–Insulin-Dependent Diabetic Patients With MicroalbuminuriaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive diseaseEuropean Journal of Clinical Investigation, 1995
- Elevated Plasma Levels of Vwf:Ag in Hyperthyroidism are Mediated Through Beta-Adrenergic ReceptorsEndocrine Research, 1993
- Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitusThe Lancet, 1992
- FEATURES OF ENDOTHELIAL DYSFUNCTION IN EARLY DIABETIC NEPHROPATHYThe Lancet, 1989
- Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatmentJournal of Endocrinological Investigation, 1988
- HYPOTHYROIDISM AS A CAUSE OF ACQUIRED VON WDLLEBRAND'S DISEASEThe Lancet, 1987
- Factor VIII Activity and Thyroid FunctionAnnals of Internal Medicine, 1982
- Low Platelet Adhesiveness and Other Hemostatic Abnormalities in HypothyroidismAnnals of Internal Medicine, 1975
- Blood Coagulation in Thyroid DysfunctionNew England Journal of Medicine, 1965